Trichothecences, secondary metabolites produced by Fusarium, are serious health risks to humans and animals worldwide. Although type A trichothecence-induced food refusal has been observed, the mechanism underlying the anorexia caused by these compounds is not fully understood. In this study, we hypothesized that anorexia induced by type A trichothecenes, including T-2 toxin (T-2), HT-2 toxin (HT-2), diacetoxyscirpenol (DAS), and neosolaniol (NEO), in mice corresponds to the changes in the gut satiety hormones peptide YY ) and glucose-dependent insulinotropic polypeptide (GIP) in plasma. A well-characterized mouse food refusal model was used in this assay. Oral exposure to or intraperitoneal (ip) injection of 1 mg/kg bw T-2, HT-2, DAS, or NEO resulted in dramatically decreased food intake, and PYY 3-36 and GIP concentrations were elevated accordingly. Specifically, the PYY 3-36 and GIP concentrations peaked at 2 h following oral exposure to these 4 toxins individually, although the durations were not identical. After ip administration of T-2 or HT-2, PYY 3-36 significantly increased within 6 h. However, no significant difference was found in the DAS and NEO groups. The GIP levels peaked within 2, 2, 0.5, and 0.5 h, respectively, and remained increased up to 6, 6, 2, and 6 h, respectively, following T-2, HT-2, DAS, or NEO ip exposure. The increase in GIP was greater than that of PYY 3-36 after exposure to the 4 toxins using 2 administration routes. Together, these findings suggest that PYY 3-36 and GIP play a role in T-2-, HT-2-, DAS-, and NEO-induced anorexia.
1989; Meeting and Organization, 2001; Wu et al., 2010) . The molecular structures of type A trichothecences are shown in Figure  1 . In Europe, 20% of 3490 cereal-derived samples were shown to be T-2-positive (Schothorst and Egmond, 2004) . T-2 exposure can induce food refusal in various animals, including chickens, swine and rodents (Burditt et al., 1983; Hayes and Schiefer, 1982; Rafai et al., 1995; Wu et al., 2015) . In the livers and intestines of mice, pigs, rabbits, and rats, T-2 is metabolized in vitro by selective hydrolysis at C-4, and HT-2 is the major metabolite of this process (Ohta et al., 1977; Wu et al., 2010) . Measurement of T-2 toxicity in vivo generally includes that of HT-2, because T-2 can be rapidly metabolized into HT-2 and the acute toxicity of T-2 and HT-2 is within the same range (Schuhmacher-Wolz et al., 2010) . Thus, data regarding HT-2 toxicity are very limited. Another T-2 metabolite, DAS, can cause weight loss and feed refusal in broiler breeders (Brake et al., 2000) . A portion of T-2 can also be transformed into NEO by rat intestinal strips (Yoshizawa et al., 1980) . Food intake determines the homeostatic regulation of energy expenditure (Murphy and Bloom, 2006) . Energy homeostasis is regulated by central signals, such as those from the hypothalamus, area postrema and brain stem, and peripheral signals, which include neural and hormonal messages from the gut (Borison, 1989; Grill and Kaplan, 2002; Wan et al., 2015) . Satiety hormones secreted by endocrine cells, such as peptide YY ) and glucose-dependent insulinotropic polypeptide (GIP), are known to physiologically inhibit food consumption (Batterham et al., 2002; Chelikani et al., 2005; Manning and Batterham, 2014; Baggio and Drucker, 2007) . PYY , first isolated from porcine intestine, is an agonist of the neuropeptide Y2 receptors (NPY2R) that is released from endocrine L cells of the gut postprandially (Tatemoto, 1982) . In a previous study, Adrian et al. (1985) demonstrated that the postprandial PYY 3-36 concentration was proportional to the amount of food intake; however, the duration of fasting before measurement critically affected the PYY 3-36 concentration (Tovar et al., 2004) . Acute, peripheral administration of PYY 3-36 reduced food consumption in humans and rodents (Batterham et al., 2003; Moran et al., 2005) . Interestingly, Pyy-null mice are hypersensitive to exogenous PYY 3-36 and easily develop prominent obesity due to hyperorexia (Batterham et al., 2006) . Another satiety hormone, GIP, a 42-residue peptide, is released from duodenum K cells and acts as an important incretin hormone (Chey, 1994) . The plasma concentration of GIP increases postprandially by 10-to 20-fold in response to nutrient ingestion (Irwin et al., 2010) . GIP can inhibit gastric acid secretion in dogs but only at supraphysiological doses (Nauck et al., 1992) .
The purpose of this study was to determine whether anorexia induced by the type A trichothecenes T-2, HT-2, DAS, and NEO in mice corresponds to the changes in the gut satiety hormones PYY 3-36 and GIP in plasma. In this report, we demonstrated that T-2, HT-2, DAS, and NEO reduced food intake and elevated plasma PYY 3-36 and GIP concentrations accordingly. In addition, we found that the increase of GIP was greater than that of PYY 3-36 in plasma following intraperitoneal (ip) injection and oral exposure. The goal of this study was to elucidate the mechanisms underlying the T-2-, HT-2-, DAS-, and NEOinduced anorexic responses.
MATERIALS AND METHODS
Laboratory animals. Female B6C3F1 mice, aged 10-12 weeks, were obtained from the Beijing Vital River Laboratory Animal Technology Co. (Beijing, P.R. China). All animals were housed in a specialized animal feeding room that was maintained at 21 C Toxins and drugs. T-2 and HT-2, with purities of 98% and 96% (Thin layer chromatography), respectively, were purchased from Toronto Research Chemicals (Toronto, Ontario, CA). DAS and NEO were purchased from Sigma-Aldrich (St. Louis, Missouri, USA) and both had a purity ! 98% (High Performance Liquid Chromatography). T-2, HT-2, DAS, and NEO were dissolved with 1% dimethyl sulfoxide, individually, and were then diluted with filter-sterilized phosphate-buffered saline (PBS) to obtain 1 mg/kg bw T-2, HT-2, DAS and NEO for oral gavage or ip injections. The time point selection was based on the results of a previous experiment (unpublished) . The delivery volumes were 1 ml/kg BW for oral gavage and ip administration. The toxins were ip administered to animals through a disposable sterilized syringe. A mouse GIP ELISA kit was obtained from Millipore (Billerica, MA), and a PYY 3-36 EIA kit was obtained from Phoenix (Burlinggame, CA).
Experimental design. The aim of this study was to examine the relationships between the characteristics of T-2-, HT-2-, DAS-, and NEO-induced anorexia and the timing of PYY 3-36 and GIP release. The bioassay used to determine anorexia induction was based on a study by Flannery et al. (2011) . The experimental design for hormones release is an adaptation from Wu et al. (2014a) . The mice were divided into groups (n ¼ 6/group) after they were acclimated for 1 week. At 10:00, all animals began fasting with freely available water for 10 h. At 18:00, all animals were given PBS or toxins by oral gavage or ip injection. Cumulative food consumption was measured following the time points described in Figure 2A . Following oral administration of 1 mg/kg bw T-2 and HT-2, blood was collected at 0.5, 2, 6, and 24 h, while blood was only collected at 0.5, 2, and 6 h following the oral gavage with DAS and NEO. Similarly, blood was collected at 0.5, 2, 6, and 24 h following the ip administration of all toxins ( Figure 2B ). The mice were anesthetized with ether in a suitable container. Blood samples were collected via the inferior vena cava into Vacutainer tubes containing EDTA and were gently rocked several times for anti-coagulation. The blood was transferred to centrifuge tubes and centrifuged at 1600 Â g for 15 min at 4 C, and then, the plasma was collected. The plasma was kept at À80 C until use. The concentrations of plasma PYY 3-36 and GIP were measured according to kit instructions.
Statistical analysis. All data were plotted and statistically analyzed with SigmaPlot 11. Differences between means were considered significant at a value of p < .05. Two-way repeated ANOVA (1 factor) with Bonferroni t tests was used to analyze the difference between the toxin groups and the control. One-way ANOVA with Holm-Sidak tests was used to assess significant differences in the kinetics of PYY 3-36 or GIP plasma concentrations compared with those of the control (Wu et al., 2016) . Two-way ANOVA with Holm-Sidak tests was used to assess the difference in plasma hormone concentrations at different times compared with the 0 h values.
RESULTS
Robust food refusal was observed in mice at 0.5, 2, 6, and 24 h following the oral administration of 1 mg/kg bw T-2 ( Figure 3A ). Consistent with this pattern, a significant increase in plasma PYY 3-36 was observed at 0.5, 2, and 6 h. The PYY 3-36 concentrations of the toxin groups were 20.12%, 39.68%, and 24.53% higher than those of the control groups at 0.5, 2, and 6 h, respectively, resulting in a significant difference (p < .05) ( Figure 3B ). The GIP concentration in the experimental group was markedly increased (96.50% and 30.10% higher than that of the control group at 2 and 6 h, respectively) ( Figure 3C ). A significant decrease in food consumption was observed at 0.5, 2, 6, and 24 h ( Figure 3D ) following the ip administration of T-2. The PYY 3-36 plasma concentration was significantly elevated at 2 and 6 h postexposure but returned to vehicle control concentrations by 24-h posttreatment ( Figure 3E ). Plasma GIP levels sharply increased during the first 2 h and returned to basal levels at 24 h according to the following pattern: 116.22% (0.5 h), 268.81% (2 h), and 80.87% (6 h) ( Figure 3F ). When mice were subjected to oral gavage and ip administration of HT-2 at 1 mg/kg bw, a significant food reduction was observed over 24 h (Figs. 4A and D) . Consistent with this pattern, PYY 3-36 concentration increases of 43.91% and 48.51% were observed at 0.5 and 2 h, respectively, and returned to the basal concentration at 6 h after oral exposure ( Figure 4B ). The observed trend in GIP variation was similar to that reported for oral gavage with 1 mg/kg bw T-2, resulting in 53.27% and 22.44% increases in GIP concentrations ( Figure 4C ). Exposure to 1 mg/kg bw HT-2 (ip) substantially also elevated plasma PYY 3-36 and GIP concentrations. Plasma PYY 3-36 increased from 0.5 to 6 h, peaked at 2 h, and returned to the basal concentration at 24 h ( Figure 4E ). Plasma GIP concentration robustly increased at 0.5 h Figure 2 . A, Experimental design of the mouse anorexia bioassay. Before the dark feeding cycle, mice were immediately exposed to T-2, HT-2, DAS, and NEO via oral gavage or ip administration. Food intakes were measured at 0.5, 2, 6, and 24 h postadministration. B, Experimental design of the mouse type A trichothecene-induced plasma PYY 3-36 and GIP release assay. Mice were given either oral gavage or an ip injection of type A trichothecenes immediately before the dark feeding cycle. PYY 3-36 and GIP plasma concentrations were analyzed at 0.5, 2, 6, and 24 h postadministration. The experimental design for hormones release is similar to that of Wu et al. (2014a) . (137.58%), 2 h (154.79%), 6 h (57.78%), and returned to vehicle control concentration by 24 h ( Figure 4F ). A significant reduction in food consumption occurred at 2 h and a more severe reduction effect was found at 6 h following oral administration of 1 mg/kg bw DAS ( Figure 5A ). A slight change in the plasma PYY 3-36 concentration was observed with only the concentration at 2 h being significantly greater compared with controls ( Figure 5B ). Similar to the change in PYY 3-36 concentration, the GIP concentration was elevated (by 65.61%) only at 2 h after administration ( Figure 5C ). Exposure to 1 mg/kg bw DAS (ip) reduced food consumption for 24 h ( Figure 5D ). Significant GIP release was observed at 0.5, 2, and 6 h, peaking at 0.5 h (186.49%) ( Figure 5F ). Although the PYY 3-36 concentration was also increased, no significant differences compared with the vehicle control group were observed ( Figure 5E ).
Similar to DAS, oral exposure to 1 mg/kg bw NEO decreased food consumption for 6 h ( Figure 6A ). The plasma PYY 3-36 concentration was increased (18.49%) during the first 2 h and was decreased during the next 4 h ( Figure 6B ). The plasma GIP concentration increased at 0.5 h (39.16%), peaked at 2 h (82.08%), and remained elevated at 6 h (23.5%) ( Figure 6C ). The ip administration of 1 mg/kg bw NEO decreased food consumption for 24 h ( Figure 6D ) and significantly increased GIP concentration from 0.5 to 6 h, but concentrations were not elevated at 24 h ( Figure 6F ). PYY 3-36 concentration did not increase after ip administration of NEO ( Figure 6E ).
DISCUSSION
Type A trichothecences, particularly T-2, HT-2, DAS, and NEO, have been shown to significantly affect appetite and are health risks to humans and animals; however, the underlying mechanism of type A trichothecence-impaired food intake is poorly understood. Thus, it is essential to determine how these toxins can induce anorexic responses and to clarify the underlying mechanism. In this study, we observed that oral and ip administration of 1 mg/kg bw T-2, HT-2, DAS and NEO individually led to significant food refusal in mice and elevated 2 gut satiety hormones PYY 3-36 and GIP. However, no difference in PYY was found in the DAS and NEO groups compared with the control group following ip injection. This study demonstrates that plasma PYY 3-36 and GIP played important roles in T-2-, HT-2-, DAS-, and NEO-induced anorexia in mice.
In humans, the postprandial concentration of plasma PYY 3-36 increases rapidly within 15 min and can last 6 h (Adrian et al., 1985) . A significant PYY 3-36 increase of 41% was observed in female adolescents following a liquid mixed meal (Stock et al., 2005) . Following acute ip exposure to DON at 1 mg/kg bw, an approximately 2-fold increase in PYY 3-36 compared with that of the zero time control was observed from 15 to 180 min in mice (Flannery et al., 2012) . As demonstrated here, T-2, HT-2, DAS, and NEO induced the above effects by stimulating the rapid release of the satiety hormone PYY 3-36 in plasma. The rapid increase in PYY 3-36 following T-2, HT-2, DAS, or NEO exposure (ip or oral) corresponded to the anorexia induced by these 4 toxins; however, no differences in PYY 3-36 concentrations compared with control were found in the DAS and NEO groups with ip injection, although the concentrations slightly increased.
PYY 3-36 can induce signaling changes within the hypothalamus by crossing the blood-brain barrier (Abbott et al., 2005) and acting through NPY2R, which is located either on the vagal afferents or in the arcuate nucleus (Cheng et al., 1998; Dumont -sensing receptor (CaSR) and transient receptor potential ankyrin-1 (TRPA1) were found to play critical roles in DONinduced anorexia and plasma PYY 3-36 elevation (Wu et al., 2017) . PYY 3-36 may play a role in toxin-induced anorexia via the arcuate nucleus NPY2R in the gut-hypothalamic pathway, which may also involve CaSR as well as TRPA1 (Batterham et al., 2002; Dumont et al., 2007) . However, the food refusal effects were still observed after exposure to 4 toxins; thus, other factors, such as hypothalamus, hindbrain, and satiety hormones, may also be involved in the regulation of energy homeostasis (Coll et al., 2007; King, 2006; Schwartz et al., 2000) .
Although GIP is a satiety hormone, its relationship to trichothecenes is poorly understood. Plasma GIP elevation and predominant food refusal were observed following the oral administration of 1 mg/kg bw T-2, HT-2, DAS, and NEO. The concentrations of GIP increased within 2 h and persisted for 6, 6, 2, and 6 h, respectively, after exposure to the 4 toxins individually. In addition to oral administration, ip exposure to 1 mg/kg bw T-2, HT-2, DAS and NEO also increased plasma GIP concentrations from 0.5 to 6 h. These data indicate that GIP participates in T-2-, HT-2-, DAS-, and NEO-induced anorexia. The results can be explained by GIP's incretin hormone role; it can be secreted within minutes of nutrient ingestion (Baggio and Drucker, 2007) . Serum levels of GIP rise to a peak of 1.4 6 0.2 ng (at 25 min) or 2.99 6 0.43 ng/ml (at 135 min) following oral administration of 2.0 g/kg bw glucose or 66 g triglycerides (Pederson et al., 1975) . The toxins in this study may act similar to nutrients that can activate GIP release. When healthy male subjects are in fasting and hypoglycemic conditions, intravenously administered GIP can significantly increase glucagon concentrations during the first 30 min compared with that of saline (76 6 17 vs 28 6 16 pmol/l) (Christensen et al., 2011) . Interestingly, following acute ip administration of 2.5 and 10 mg/kg bw DON, no change was found in plasma GIP in mice (Flannery et al., 2012) . Possible reasons for divergent findings might include different toxin, dose selection and methods for hormone analysis.
GIP controls food intake via activation of the GIP receptor (GIPR), which is a G-protein-coupled receptor (Usdin et al., 1994) . The activation of GIPR signaling increases the levels of cAMP and intracellular Ca 2þ (Zhong et al., 2000) . GIP acts as a physiological bifunctional blood glucose stabilizer and regulates the glucose level via divergent effects on the 2 major pancreatic gluco-regulatory hormones, insulin and glucagon (Christensen et al., 2011) . Using identical toxin exposure methods, we found that the elevated concentration of plasma GIP was more pronounced and therefore may play a more important role than that of PYY 3-36 in type A trichothecene-evoked anorexia. Batterham et al. (2002) demonstrated that PYY 3-36 plays a role in the "longer term" regulation of food intake; however, in the present study, the maximum duration of increased PYY 3-36 concentration was 6 h, shorter than the 12 h reported by Batterham. The reasons for this discrepancy may be due to the use of different species and treatment methods. Although GIP production largely depends on glucose and fat ingestion (Elliott et al., 1993; Kieffer, 2003) , toxins could also stimulate GIP release in this study.
It was particularly notable that in some cases type A trichothecenes-induced anorectic response occurred before elevation of PYY 3-36 and GIP, suggesting that other appetite modulating factors might be involved. The contribution of gut satiety hormone cholecystokinin (CCK) in DON and other type B trichothecenes-induced anorexia was investigated (Wu et al., 2014a,b) . CCK is an effective short-term, meal-reducing signal in both human and animals (Dockray, 2009; Strader and Woods, 2005) . In those studies, DON and other type B trichothecenes markedly elevated plasma CCK concentrations within 0.5 h, a time that coincided with the initiation of significant anorectic response. In addition to satiety hormone, 5-hydroxytryptamine (5-HT) and proinflammatory cytokines also might involve in anorexia induction. 5-HT, a neurotransmitter produced primarily in the gastrointestinal tract (Kim and Camilleri, 2000) , has been implicated in DON-induced anorectic response as well as emesis. Following ip exposure to DON in mink, significant elevation of plasma 5-HT was observed within 1 h (Wu et al., 2013) . It was also observed that blocking the 5-HT 2 and 5-HT 3 receptor would inhibit DON-induced anorectic and emetic response in mice and mink, respectively (Prelusky et al., 1997; Wu et al., 2013) . DON and other type B trichothecenes are known to rapidly induce proinflammatory cytokines including interleukin-1b, interleukin-6 and tumor necrosis factor-a (Clark et al., 2015; Pestka and Amuzie, 2008; Wu et al., 2014c) . Such a cytokine storm could elicit a sickness response with anorexia as a hallmark (Plata-Salaman, 1998). It might be further speculated that the mechanisms by which the type A trichothecenes induce anorectic response are the same as type B trichothecenes; however, further research will be needed to clarify this possibility.
In conclusion, the observations that T-2, HT-2, DAS, and NEO increased both plasma PYY 3-36 and GIP concentrations in mice following oral and ip administration indicate that these 2 hormones play important roles in type A trichothecene mycotoxin-elicited anorexia. This study will facilitate the further understanding of the basal mechanisms of these trichothecenes in induced anorexia and their effects on human and animal nutritional homeostasis and energy balance. However, the exact mechanism underlying the relationship between PYY 3-36 and GIP elevation by type A trichothecene mycotoxins remains unknown. We elucidated only a small part of the trichothecene-induced food refusal process; therefore, further research is definitely warranted.
